HAE
$71.48
Revenue | $336.17Mn |
Net Profits | $38.37Mn |
Net Profit Margins | 11.41% |
PE Ratio | 31.91 |
Haemonetics Corp’s revenue jumped 7.98% since last year same period to $336.17Mn in the Q2 2024. On a quarterly growth basis, Haemonetics Corp has generated -2.07% fall in its revenue since last 3-months.
Haemonetics Corp’s net profit fell -6.5% since last year same period to $38.37Mn in the Q2 2024. On a quarterly growth basis, Haemonetics Corp has generated 88.41% jump in its net profits since last 3-months.
Haemonetics Corp’s net profit margin fell -13.41% since last year same period to 11.41% in the Q2 2024. On a quarterly growth basis, Haemonetics Corp has generated 92.4% jump in its net profit margins since last 3-months.
Haemonetics Corp’s price-to-earnings ratio after this Q2 2024 earnings stands at 31.91.
EPS Estimate Current Quarter | 1.07 |
EPS Estimate Current Year | 1.07 |
Haemonetics Corp’s earning per share (EPS) estimates for the current quarter stand at 1.07 - a 5.94% jump from last quarter’s estimates.
Haemonetics Corp’s earning per share (EPS) estimates for the current year stand at 1.07.
Earning Per Share (EPS) | 1.02 |
Return on Assets (ROA) | 0.06 |
Return on Equity (ROE) | 0.13 |
Haemonetics Corp’s earning per share (EPS) fell -2.86% since last year same period to 1.02 in the Q2 2024. This indicates that the Haemonetics Corp has generated -2.86% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Haemonetics Corp’s return on assets (ROA) stands at 0.06.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Haemonetics Corp’s return on equity (ROE) stands at 0.13.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-05-20 | 0.89 | 0.9 | 1.12% |
2024-08-08 | 1.01 | 1.02 | 0.99% |